Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

Size: px
Start display at page:

Download "Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles"

Transcription

1 Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS, BCGP ASSISTANT PROFESSOR, GERIATRICS DIVISION TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF PHARMACY JANUARY 27, 2018 Objectives Why should we care? Discuss the most common long-term care pathogens and the antibiotics most effective in treating them Evaluate antibiogram accessibility and applicability to the long-term care environment Identify 3 items a consultant pharmacist can monitor easily during a monthly medication review to make an impact on antimicrobial stewardship Provide recommendations to facility leadership with regard to interventions necessary to improve antimicrobial stewardship Increasing colonization rates in nursing homes Organism Healthcare-associated infections increasing among older adults in long-term care facilities 11.5% prevalence > 85 years of age Colonization Rates Vancomycin-Resistant Enterococcus (VRE) 33% Clostridium difficile 4-30% Methicillin-resistant S. aureus (MRSA) 30% Multidrug resistant Enterobacteriaceae spp. (Klebsiella spp., Proteus spp., etc.) 20% Why should we care? Antibiotics contribute to approximately 20% of adverse drug events 40% of hospice patients on antibiotics in last 2 weeks of life May not have appropriate symptoms Associated with decreased comfort What are potential limitations in geriatric care settings? Access to lab and microbiology reports Nursing staff to administer appropriate antibiotics Funding Time Difficulty with diagnosing infections Lack of geriatrics training in medical education 1

2 Specific Infectious Diseases Pneumonia Clostridium difficile Urinary Tract Infections Skin and Soft-Tissue infections Cellulitis Osteomyelitis Urinary Tract Infection Common Pathogens: Escherichia coli - still #1 likely pathogen Proteus mirabilis Klebsiella oxytoca Not as common: Staphylococcus spp. Enterococcus spp Pseudomonas aeruginosa Urinary Tract Infection Where is the infection? Cystitis vs. Pyelonephritis Uncomplicated vs. Complicated Catheter vs. No catheter Symptoms vs. No symptoms Unfortunately these questions play into treatment decisions and durations Urinary Tract Infection Uncomplicated Cystitis Nitrofurantoin 100 mg BID x 5 days Trimethoprim/Sulfamethoxazole DS BID x 3 days Fosfomycin 3 g x 1 dose Amoxicillin-clavulanate 875/125 (or 500/125) mg PO BID x 7 days Uncomplicated Pyelonephritis Ciprofloxacin 500 mg PO BID x 7 days (can also do IV) Trimethoprim/sulfamethoxazole DS BID x 14 days Maybe: Tobramycin (weight based) IV daily Maybe: Ceftriaxone 1 gram IV daily Complicated: use the same drugs but treat between 7 14 days (most likely days) Fluoroquinolones should not be as relied upon unless needed Other Treatment Pearls Pneumonia Nitrofurantoin Great for E. coli coverage, but not P. mirabilis Sulfamethoxazole/Trimethoprim Great for patients with a history of gramnegative infections Remember to tailor antibiotics once susceptibilities are known Duration: still similar depending on if the infection is complicated or uncomplicated Likely to receive longer courses of antibiotic treatment Common Pathogens: Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis Mycoplasma pneumoniae Chlamydiophila pneumoniae Staphylococcus aureus Likely may not even get cultures due to inaccuracy of sputum Infect Drug Resist. 2013;7:1-7 2

3 Pneumonia Risk Factors for Drug Resistance Drug Resistant Strep. Pneumoniae Prior antibiotic therapy Alcoholism Immunosuppres sion Multiple Comorbidities Atypical Pathogens Increased age (over 65 years) LTCF residency Pseudomonas aeruginosa Severe COPD Oral corticosteroids Alcoholism Recent antibiotic use Diabetes mellitus??? Pneumonia - CAP Setting Outpatient Inpatient (non-icu) Inpatient (ICU) Pseudomonas CA-MRSA Treatment No use of antibiotics in past 90 days: Macrolide or doxycycline Comorbidities or use of antibiotics: Respiratory fluoroquinolone or Beta-lactam plus macrolide Respiratory fluoroquinolone Beta-lactam plus macrolide Beta-lactam plus macrolide Respiratory fluoroquinolone Antipneumococcal and Antipseudomonal Beta-lactam PLUS ciprofloxacin or levofloxacin (750 mg dose) or aminoglycoside + macrolide Add vancomycin or linezolid May also need to consider clindamycin if treating orally (Due to presence of PVL) CID. 2007;44:S27-S72 What secret code words did I just say? Respiratory fluoroquinolone: levofloxacin or moxifloxacin Macrolide: Azithromycin Beta-lactam: amoxicillin-clavulanate, cephalosporins (cephalexin, ceftriaxone, etc) Aminoglycoside: gentamicin or tobramycin Antipneumoccal: drugs that cover S. pneumo Antipseudomonal: drugs that cover P. aeruginosa Pneumonia - HAP Not at High Risk of Mortality or MRSA Piperacillin-Tazobactam 4.5 grams IV q 6 Cefepime 2 g IV q8 Levofloxacin 750 mg IV daily *Imipenem 500 mg IV q6 *Meropenem 1 gram IV q8 Risk Factors for MRSA Piperacillin-Tazobactam 4.5 grams IV q 6 Cefepime 2 g IV q8 Levofloxacin 750 mg IV daily Ciprofloxacin 400mg IV q8 *Imipenem 500 mg IV q6 *Meropenem 1 gram IV q8 Aztreonam 2 g IV q8 PLUS: Vancomycin 15mg/kg (may need to load) OR Linezolid 600 mg IV q12 Increased Mortality or recent IV antibiotics Piperacillin-Tazobactam 4.5 grams IV q 6 Cefepime 2 g IV q8 Levofloxacin 750 mg IV daily Ciprofloxacin 400mg IV q8 *Imipenem 500 mg IV q6 *Meropenem 1 gram IV q8 Aztreonam 2 g IV q8 Gentamicin/Tobramycin 5-7 mg/kg daily; or Amikacin mg/kg daily PLUS: Vancomycin 15mg/kg (may need to load) OR Linezolid 600 mg IV q12 CID. 2016; 63(5):e Pneumonia treatment pearls HCAP no longer covered in guidelines New CAP guidelines in Spring 2018 Daptomycin should not be used for treatment of pneumonia even if the pathogen is MRSA, VRE, etc. Duration: HAP 7 days CAP 5 days If afebrile no CAP sign of instability: STOP Monotherapy with macrolide not recommended for older adults Aspiration: may need to add clindamycin Clostridium difficile New guidelines any day No more metronidazole therapy for treatment Fidaxomicin (Dificid ) should be included for recurrent C. diff Bezlotoxumab (Zinplava 0 likely not going to be included in new update Mainstay of therapy: Oral vancomycin x days 125 mg Depends on severity White count elevation Serum Creatinine Caution with probiotics 3

4 Skin and Soft-Tissue Infections Skin and Soft-Tissue Infections Common pathogen: Staphylococcus spp. Streptococcos spp. Pseudomonas aeruginosa Diabetic patients Wounds increase risk of resistant pathogens Also increase risk of bacteremia Not as common of infections in nursing homes, but growing especially in rehab and LTACs Many times will be continuing treatment from the hospital Often still on IV therapy Do not treat older adults differently Be cautious with cultures Purulent wounds are more likely to get an accurate cultures (abscess) Blood cultures more beneficial Durations: Cellulitis: 5-7 days Abscess: One time: may not even need antibiotics Recurrent: 5-10 days Osteomyelitis: 6 weeks Chronic osteomyelitis: 12 weeks (lack of literature) CID. 2014; 59(2):e CID. 2014; 59(2):e Skin and Soft-Tissue Infections Lots of antibiotic choices Non MRSA/MSSA MSSA MRSA Dicloxacillin 250 mg Cephalexin 250 mg Erythromycin 250 mg Clindamycin Amoxicllin-clavulanate 875/125 BID Nafcillin 1-2 g IV q4 Cefazolin 1g q8 Clindamycin 600 mg IV q8 Dicloxacillin 500 mg Cephalexin 500 mg Sulfamethoxazoletrimethoprim DS 1-2 tabs BID Vancomycin (weight based/renal function) Linezolid 600 mg IV/PO BID Clindamycin 600 mg IV q8 Daptomycin 4mg/kg IV qday Ceftaroline 600 mg IV BID Sulfamethoxazoletrimethoprim DS 1-2 tabs BID Self-Assessment Question #1 Which of the following pathogens is the most common in urinary tract infections? A. Escherichia coli B. Moraxella catarrhalis C. Pseudomonas aeruginosa D. Staphylococcus aureus CID. 2014; 59(2):e Self-Assessment Question #1 Which of the following pathogens is the most common in urinary tract infections? A. Escherichia coli B. Moraxella catarrhalis C. Pseudomonas aeruginosa D. Staphylococcus aureus Using an antibiogram What is an antibiogram? Overall profile of antimicrobial susceptibility testing results of a specific microorganism to a battery of antimicrobial drugs How is it developed? Performed annually At least 30 isolates required for inclusion in analysis Isolates from diagnostic testing Do not include MRSA screenings or colonizers Include antibiotics that are routinely tested Use only a first isolate from a patient Evaluating percentage susceptible Indian J Med Microbiol. 2010;28(4):

5 Here s what it could look like CIP LEV IMP MER NTF SMX/TMP TOB E. coli 28% 58% 100% 100% 95% 86% 96% P. mirabilis 36% 68% 95% 97% 98% 82% 99% K. oxytoca 48% 41% 90% 92% 92% 84% 95% Presentation and Utility of Antibiograms Gram-positive and gram-negative species should be split into their own tables Remember different antibiotics cover different pathogens Make them available Reporting on different levels of care within institution ICUs: 5-25% more resistant organisms compared to other units Monitoring of antibiotic resistance rates Establish facility-specific empiric antibiotic recommendations Indian J Med Microbiol. 2010;28(4): Infect Control Hosp Epidemiol. 2006;27:682-7 Effectiveness of Antibiogram Antibiogram Approach Antibiotics chosen: Cystitis Pyelonephritis Education session after creating ED-specific antibiogram for UTI therapy Primary outcome: adherence to recommendations based on local resistance rates Nitrofurantoin 100 mg q12 x 5 days IV: Ceftriaxone 1 gram, tobramycin or gentamicin 5-7 mg/kg (Pharmacy to Dose) Cephalexin 500 mg q12 x 7 days PO: Ciprofloxacin 250 mg q12 x 7 days or Levofloxacin 250 mg q24 x 5 days SMX-TMP 800/160 mg q12 x 3 days SMX-TMP 800/160 mg q12 x 14 days Ciprofloxacin 250 mg q12 or Levofloxacin 250 mg q24 x 3 days Cephalexin 500 mg q6 x 14 days Am J Emerg Med. 2015;33(9): Am J Emerg Med. 2015;33(9): Antibiogram Approach Isolate susceptible Cystitis Pyelonephritis P-Value Pre- Post- Education Education N=106 (%) N=149 (%) Pre- Education N=68 (%) Post- Education N=27 (%) 74% 89% 90% 76% 0.05 / 0.23 Cephalexin 1 (0.9) 2 (1.3) 0 1 (18.5) 0.77 / 0.11 Fluoroquinolones 35 (33) 16 (12.8) 32 (47) 19 (70.4) <0.001 / 0.04 Nitrofurantoin 13 (12.3) 119 (79.9) 7 (10) 5 (18.5) <0.001 / 0.28 Antibiogram Approach Choice of empiric therapy: 44.8% Pre vs. 83% Post (P<0.001) Lowest rate of adherence was duration of therapy 16% Pre vs. 25.5% Post (P=0.029) Follow up care within 30 days: 4.6% Pre vs. 7.4% Post (P=0.27) Strengths First study to evaluate use of antibiograms in ED Strong outcomes by utilizing education Limitations Single-center observational study Follow-up care may have occurred at a different facility Misclassification as abstractor was not fully blinded SMX-TMP 56 (52.8) 8 (5.4) 29 (43) 2 (7.4) <0.001/0.001 Am J Emerg Med. 2015;33(9): Am J Emerg Med. 2015;33(9):

6 Let s Practice What did we find out? Instructions: On your table there should be some pages of culture and susceptibility reports from the lab. Break into groups at your table, and I ll assign you a couple of antibiotics to specific calculate the % susceptibility After 3-5 minutes, will discuss our findings and fill in the antibiogram E. coli Amk Amp A/S Am A/C Cip Ert Gen Lev Mer P/T T/S Tob Other Antibiogram Studies in Nursing Homes Furuno, et.al Antibiogram in SNF Appropriate antibiotic prescribing increased from 32% - 45% Prior to antibiogram: 85% of all prescriptions were empiric Kindschuh, et al Hospital antibiogram vs. LTCF Proved antibiotic resistance worse in LTCF Seen in both gram-positive and gram-negative pathogens Need to create facility specific antibiogram do not rely on your local hospital Self-Assessment Question #2 How many isolates are needed in order to create an antibiogram with a specific pathogen? A. 15 B. 30 C. 45 D. 60 Infect Control Hosp Epidemiol. 2014;35 Suppl 3:S56-61 Self-Assessment Question #2 Now it s time to ask How many isolates are needed in order to create an antibiogram with a specific pathogen? A. 15 B.30 C. 45 D. 60 6

7 Everyone is requiring it Joint Commission Centers for Disease Control and Prevention Agency for Healthcare Research and Quality Centers for Medicare and Medicaid Services Long Term Care Institute White House, and on and on CDC s Specific Tasks Facility-specific interventions Communication tools for infection Algorithms for assessing residents with infections Facility-specific antibiograms Pharmacy-specific interventions Drug regimen review (DRR) of antibiotics Review microbiology results Infection-specific interventions Reduce antibiotics in asymptomatic bacteriuria Optimize pneumonia care in nursing home patients But how does this work in LTC? Who is going to pay for it? How much more time is it? Where do I even start??????? This question is just now starting to be answered Where did my facility start? Duration of Therapy Is there a documented start date or stop date pre-specified? Incorporated this into chart review First recommendation was: when do you want the antibiotic to stop? Could match indication to anticipated duration Paid attention to antibiotic orders that were active > 14 days Put in hard stops in computer system Utilized 7 days, then drug would fall off Stop dates written in order Where did my facility start? Reviewed cultures as part of chart review Started with is there one there? Then reviewed was empiric therapy correct and effective Communicated with my team that I have some ID background and to contact me before calling the ID pharmacist Performed pharmacokinetics/renal dose adjustments on IV antibiotics What else have I done/planning to do? Education sessions with providers Antibiotics discussed twice yearly goal quarterly New Guidelines Pneumonia and Urinary Tract Infections Created hand outs for nursing staff Use of Antibiogram Disperse antibiogram Review # times our empiric treatment was effective Updating materials as antibiogram data renewed 7

8 What else have I done/planning to do? What are my struggles? Daily Discharge Huddle Interdisciplinary Started bringing up culture results IV antibiotic duration/use C.diff discussions Great thing to send students to Quality Improvement Projects Been able to be more successful at looking at data Documentation and discussion Getting support to perform these tasks on top of additional duties Student support Another pharmacist? Updating Scope of Practice/Collaborative Practice Agreements How to get administrator buy-in? Get in touch with MDS team, DON, etc Each activity for your program should line up with one of the 7 elements Pharmacists can help with 5 right off the bat Rehab facilities do worry about LOS Survey visit CDC s Core Elements Leadership Commitment Accountability Drug Expertise Action Tracking Reporting Education New: AMDA has released a stewardship policy for nursing home administrators to implement Where do we fit things in? Leadership Commitment Accountability Drug Expertise Action Tracking Reporting Monthly medication reviews Evaluating stop dates Keeping record of C. difficile infections Antibiotic Adverse Drug Events Talking with providers regarding what you have tracked Follow up from the chart review Education Inservices Summary Majority of antibiotic durations should be less than 2 weeks. If you see an antibiotic on for more than 14 days, there needs to be a documented indication Antibiograms can provide useful information, but it needs to be used wisely. Getting support to perform stewardship will be challenging, but the more that we can do, even small steps, we can start moving in the right direction 8

9 Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles KALIN M. CLIFFORD, PHARM.D., BCPS, BCGP ASSISTANT PROFESSOR, GERIATRICS DIVISION TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF PHARMACY JANUARY 27,

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016 Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate

More information

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Antibiotic Stewardship Program (ASP) CHRISTUS SETX Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:

More information

Appropriate antimicrobial therapy in HAP: What does this mean?

Appropriate antimicrobial therapy in HAP: What does this mean? Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,

More information

Antibiotic Updates: Part II

Antibiotic Updates: Part II Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

Concise Antibiogram Toolkit Background

Concise Antibiogram Toolkit Background Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions

More information

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,

More information

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial

More information

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient 1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime

More information

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects

More information

Understanding the Hospital Antibiogram

Understanding the Hospital Antibiogram Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital

More information

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California

More information

New Drugs for Bad Bugs- Statewide Antibiogram

New Drugs for Bad Bugs- Statewide Antibiogram New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda

More information

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review (1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of

More information

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,

More information

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org

More information

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an

More information

2015 Antibiotic Susceptibility Report

2015 Antibiotic Susceptibility Report Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens

More information

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University

More information

Using Data to Track Antibiotic Use and Outcomes

Using Data to Track Antibiotic Use and Outcomes Using Data to Track Antibiotic Use and Outcomes Michelle Nemec, PharmD Thrifty White Drug Pharmacy Objectives Describe the Antibiotic Stewardship Core Element of tracking and the specific interventions

More information

Objectives 4/26/2017. Co-Investigators Sadie Giuliani, PharmD, BCPS Claude Tonnerre, MD Jayme Hartzell, PharmD, MS, BCPS

Objectives 4/26/2017. Co-Investigators Sadie Giuliani, PharmD, BCPS Claude Tonnerre, MD Jayme Hartzell, PharmD, MS, BCPS IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) Lucas Schonsberg, PharmD PGY-1 Pharmacy Practice Resident Providence St. Patrick Hospital Missoula,

More information

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

2016 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates

More information

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine 2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose

More information

IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP)

IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) Lucas Schonsberg, PharmD PGY-1 Pharmacy Practice Resident Providence St. Patrick Hospital Missoula,

More information

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health

More information

Best Practices: Goals of Antimicrobial Stewardship

Best Practices: Goals of Antimicrobial Stewardship Best Practices: Goals of Antimicrobial Stewardship Gail Scully, M.D, M.P.H. and Elizabeth Radigan, PharmD, BCPS UMass Memorial Medical Center Division of Infectious Disease Department of Medicine September

More information

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015 Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New

More information

Antimicrobial Stewardship:

Antimicrobial Stewardship: Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of

More information

Antimicrobial Stewardship Program 2 nd Quarter

Antimicrobial Stewardship Program 2 nd Quarter Antimicrobial Stewardship Program 2 nd Quarter May 19, 2016 Jill Hanson, WHA DeAnn Richards, MetaStar Objectives for Today Hospital Highlight UnityPoint Health - Meriter Status of the state Update on pilot

More information

Antimicrobial Stewardship Program

Antimicrobial Stewardship Program Antimicrobial Stewardship Program David R. Woodard, MSc, FSHEA, CIC CDC: Antibiotic Resistance Threats in the United States, 2013 http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ CDC Threat Levels

More information

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? Dr. Andrew Morris Antimicrobial Stewardship ProgramMt. Sinai Hospital University Health Network amorris@mtsinai.on.ca andrew.morris@uhn.ca

More information

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives

More information

ANTIBIOTIC STEWARDSHIP IN LONG TERM CARE

ANTIBIOTIC STEWARDSHIP IN LONG TERM CARE ANTIBIOTIC STEWARDSHIP IN LONG TERM CARE How consultant pharmacists can help their facilities by Kelli Musick-Hocker, Pharm D. Complete Pharmacy Consulting Kansas City Why is antibiotic stewardship in

More information

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1 Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director

More information

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Stewardship Strategy: Antibiograms Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

Antimicrobial Stewardship 101

Antimicrobial Stewardship 101 Antimicrobial Stewardship 101 Betty P. Lee, Pharm.D. Pediatric Infectious Disease/Antimicrobial Stewardship Pharmacist Lucile Packard Children s Hospital Stanford Disclosure I have no actual or potential

More information

Antimicrobial Susceptibility Patterns

Antimicrobial Susceptibility Patterns Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department

More information

SHC Clinical Pathway: HAP/VAP Flowchart

SHC Clinical Pathway: HAP/VAP Flowchart SHC Clinical Pathway: Hospital-Acquired and Ventilator-Associated Pneumonia SHC Clinical Pathway: HAP/VAP Flowchart v.08-29-2017 Diagnosis Hospitalization (HAP) Pneumonia develops 48 hours following: Endotracheal

More information

Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance

Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance Natalie Weber, PharmD PGY2 Critical Care Pharmacy Resident September 22, 2016 The speaker has no actual or potential conflicts of

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Antimicrobial Stewardship Studies have estimated that 30 50% of antibiotics prescribed in acutecare hospitals are unnecessary or inappropriate 1 Antimicrobial stewardship definition:

More information

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

GENERAL NOTES: 2016 site of infection type of organism location of the patient

GENERAL NOTES: 2016 site of infection type of organism location of the patient GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered

More information

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM Mary Moore, MS CIC MT (ASCP) Infection Prevention Coordinator Great River Medical Center, West Burlington REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM ABOUT

More information

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally

More information

Antibiotic Stewardship in the LTC Setting

Antibiotic Stewardship in the LTC Setting Antibiotic Stewardship in the LTC Setting Joe Litsey, Director of Consulting Services Pharm.D., Board Certified Geriatric Pharmacist Thrifty White Pharmacy Objectives Describe the Antibiotic Stewardship

More information

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services 2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens

More information

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses

More information

Examples of Antimicrobial Stewardship Interventions: a couple of starter projects

Examples of Antimicrobial Stewardship Interventions: a couple of starter projects Examples of Antimicrobial Stewardship Interventions: a couple of starter projects Jennifer Ott, PharmD, BCPS Clinical Pharmacist Specialist Infectious Diseases Billings Clinic jott4@billingsclinic.org

More information

Antimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services

Antimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO

More information

OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials

OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials Clinical Monitoring of Outpatient Parenteral Antimicrobial Therapy (OPAT) and Selected Oral Antimicrobial Agents Adult Inpatient/Ambulatory Clinical Practice Guideline Appendix A. Coordinating an OPAT

More information

Measure Information Form

Measure Information Form Release Notes: Measure Information Form Version 3.0b **NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE** Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse

More information

CLINICAL USE OF BETA-LACTAMS

CLINICAL USE OF BETA-LACTAMS CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial

More information

Preserve the Power of Antibiotics

Preserve the Power of Antibiotics PROVIDERInsight News for providers in Northeast Nebraska April 2016 Preserve the Power of Antibiotics Antimicrobial stewardship interventions have been proven to improve individual patient outcomes, reduce

More information

Approach to pediatric Antibiotics

Approach to pediatric Antibiotics Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus

More information

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014 H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report July December 213 Second and Third Quarters

More information

Antibiotic Stewardship in the Long Term Care Setting. Lisa Venditti, R.Ph., FASCP, Founder and CEO Long Term Solutions Inc LTSRX.

Antibiotic Stewardship in the Long Term Care Setting. Lisa Venditti, R.Ph., FASCP, Founder and CEO Long Term Solutions Inc LTSRX. Antibiotic Stewardship in the Long Term Care Setting Lisa Venditti, R.Ph., FASCP, Founder and CEO Long Term Solutions Inc. 845.208.3328 LTSRX.com 1 Resistant Bacteria Crisis The Centers for Medicare &

More information

9/9/2015. Disclosure / Contact. Pneumonia Stats. Exploring the Clinical and Regulatory Impact of Pneumonia in Long Term Care

9/9/2015. Disclosure / Contact. Pneumonia Stats. Exploring the Clinical and Regulatory Impact of Pneumonia in Long Term Care Exploring the Clinical and Regulatory Impact of Pneumonia in Long Term Care Rob Shulman R.Ph. CGP FASCP Director of Consulting Services Remedi SeniorCare William M. Vaughan,RN, BSN Vice President, Education

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic

More information

Standing Orders for the Treatment of Outpatient Peritonitis

Standing Orders for the Treatment of Outpatient Peritonitis Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.

More information

Discussion Points. Decisions in Selecting Antibiotics

Discussion Points. Decisions in Selecting Antibiotics Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical

More information

Head to Toe: Common infections in Hospital settings. Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases

Head to Toe: Common infections in Hospital settings. Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases Head to Toe: Common infections in Hospital settings Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases Objectives To identify at least one common infection in

More information

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018 Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?

More information

The Rise of Antibiotic Resistance: Is It Too Late?

The Rise of Antibiotic Resistance: Is It Too Late? The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the

More information

RCH antibiotic susceptibility data

RCH antibiotic susceptibility data RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Background Why Antimicrobial Stewardship 30-50% of antibiotic use in hospitals are unnecessary or inappropriate Appropriate antimicrobial use is a medication-safety and patient-safety

More information

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University

More information

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative Place picture here Nov. 14, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Please use the chat box to ask questions!

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

ANTIMICROBIAL STEWARDSHIP IN LONG TERM CARE FACILITIES

ANTIMICROBIAL STEWARDSHIP IN LONG TERM CARE FACILITIES ANTIMICROBIAL STEWARDSHIP IN LONG TERM CARE FACILITIES ANTIMICROBIAL STEWARDSHIP COLLABORATIVE COLORADO HOSPITAL ASSOCIATION MARCH 23, 2016 Bridget Olson, RPh Infectious Disease Pharmacist, Sharp Coronado

More information

Ready to Launch: Antimicrobial Stewardship for All!

Ready to Launch: Antimicrobial Stewardship for All! Ready to Launch: Antimicrobial Stewardship for All! Lucas Schulz, PharmD, BCPS AQ ID Clinical Coordinator Infectious Diseases PGY2 Infectious Diseases Residency Program Director Disclosures Consultant

More information

Understand the application of Antibiotic Stewardship regulations in LTC. Understand past barriers to antibiotic management concepts

Understand the application of Antibiotic Stewardship regulations in LTC. Understand past barriers to antibiotic management concepts Objectives Understand the application of Antibiotic Stewardship regulations in LTC Understand past barriers to antibiotic management concepts Understand benefits of adoption of antibiotic stewardship regulations

More information

Antibiotic Updates: Part I

Antibiotic Updates: Part I Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck! Medicinal Chemistry 561P 2 st hour Examination May 6, 2013 NAME: KEY Good Luck! 2 MDCH 561P Exam 2 May 6, 2013 Name: KEY Grade: Fill in your scantron with the best choice for the questions below: 1. Which

More information

Antibiotic Stewardship: The Facility Role and Implementation. Tim Cozad, LPN, Lead LTC Health Facilities Surveyor

Antibiotic Stewardship: The Facility Role and Implementation. Tim Cozad, LPN, Lead LTC Health Facilities Surveyor Antibiotic Stewardship: The Facility Role and Implementation Tim Cozad, LPN, Lead LTC Health Facilities Surveyor Phase II CMS Regulatory Changes Current information available includes: New Survey Process

More information

Antimicrobial Stewardship in Ambulatory Care

Antimicrobial Stewardship in Ambulatory Care Antimicrobial Stewardship in Ambulatory Care Nila Suntharam, M.D. May 5, 2017 Dr. Suntharam indicated no potential conflict of interest to this presentation. She does not intend to discuss any unapproved/investigative

More information

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) VA Palo Alto Health Care System April 14, 2017 Trisha Nakasone, PharmD, Pharmacy Service Russell Ryono, PharmD, Public Health Surveillance

More information

Guidelines for Treatment of Urinary Tract Infections

Guidelines for Treatment of Urinary Tract Infections Guidelines for Treatment of Urinary Tract Infections Overview This document details the Michigan Hospital Medicine Safety (HMS) Consortium preferred antibiotic choices for treatment of uncomplicated and

More information

Standing Orders for the Treatment of Outpatient Peritonitis

Standing Orders for the Treatment of Outpatient Peritonitis Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.

More information

1. List three activities pharmacists can implement to support. 2. Identify potential barriers to implementing antimicrobial

1. List three activities pharmacists can implement to support. 2. Identify potential barriers to implementing antimicrobial OPTIMIZING ANTIMICROBIAL STEWARDSHIP: IT STARTS IN THE EMERGENCY DEPARTMENT! 1 2 Objectives 1. List three activities pharmacists can implement to support health-system antimicrobial stewardship programs

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007

More information

Solution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim

Solution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim Solution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim Program/Project Description, including Goals What was the problem to be solved? How was it identified? What baseline data existed?

More information

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes

More information

CARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE)

CARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE) CARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE) Bartsch SM et al. Potential economic burden of carbapenem-resistent Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect 2017;23(1):48e9-e16.

More information

Core Elements of Antibiotic Stewardship for Nursing Homes

Core Elements of Antibiotic Stewardship for Nursing Homes Core Elements of Antibiotic Stewardship for Nursing Homes Nimalie D. Stone, MD, MS Medical Epidemiologist for LTC Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Antimicrobial

More information

Antimicrobial Stewardship: The Premier Health Experience

Antimicrobial Stewardship: The Premier Health Experience Antimicrobial Stewardship: The Premier Health Experience Steve Burdette, MD, FIDSA Professor of Medicine Wright State University Boonshoft School of Medicine Director of Antimicrobial Stewardship Miami

More information

Antibiotic stewardship in long term care

Antibiotic stewardship in long term care Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts

More information

Advanced Practice Education Associates. Antibiotics

Advanced Practice Education Associates. Antibiotics Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright

More information

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Last Updated: Version 3.2a NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form Organization Set Measure ID#

More information

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier

More information

Antibiotic Stewardship at MetroWest Medical Center. Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee

Antibiotic Stewardship at MetroWest Medical Center. Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee Antibiotic Stewardship at MetroWest Medical Center Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee Antibiotic Stewardship Committee Subcommittee of Pharmacy and Therapeutics. Also

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information